Corporate Profile

Overview

Company name Summit Pharmaceuticals International Corporation
Established

November 21, 1949

Capital

¥480 million (wholly-owned subsidiary of Sumitomo Corporation)

Representative Kenichi Nakamura, President & CEO
Number of employees

143(as of July 2018)

Sales

¥22.3 billion (year ended March 2018)

Head Office

1-2-2, Hitotsubashi, Chiyoda-ku, Tokyo 100-0003
Sumitomo Corporation Takebashi BLD. 12F
Tel: +81-(0)3-5220-1500 Fax: +81-(0)3-5220-1501

Osaka Office

4-5-33 Kitahama, Chuo-ku, Osaka City 541-0041
Sumitomo Main Bldg. 7F
Tel: +81-(0)6-6222-3971 Fax: +81-(0)6-6222-6770

Yokohama Support Center

1-6 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045
Yokohama Bio Production Center
Tel: +81-(0)45-508-2171 Fax: +81-(0)45-508-2710

API Laboratory

3-2-1 Sakado, Takatsu-ku, Kawasaki City, Kanagawa 213-0012
R&D B1016 Kanagawa Science Park
Tel: +81-(0)44-829-1170 Fax: +81-(0)44-844-0371